GlassScriptPhysician profile
David Azouz
NPI 1528139110
$9,447.78
in general payments reported to CMS, 2019-2025
22 companies · $980 in 2025
The $980 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $6,651 · 2021: $313 · 2022: $266 · 2023: $959 · 2024: $153 · 2025: $980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $775 · Honoraria: $700 · Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $775.00 |
| Honoraria | $700.00 |
| Food and Beverage | $617.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $6,663.14 | 2019-2020 | |
| Abbvie INC. | $775.00 | 2025 | |
| Bard Peripheral Vascular, INC. | $700.00 | 2023 | |
| Axogen | $208.70 | 2022-2024 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Medtronic, INC. | $200.13 | 2022-2025 | Ligasure, V-Loc 180 |
| Integra Lifesciences Corporation | $140.83 | 2023-2025 | Integra, Tenoglide, Integra Dermal Regeneration Template |
| Allergan, INC. | $111.39 | 2021 | |
| Tela Bio, INC. | $111.16 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $73.61 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| W. L. Gore & Associates, INC. | $66.44 | 2021 | |
| Sanara Medtech INC. | $62.18 | 2021 | |
| Baudax Bio INC. | $59.35 | 2021 | |
| Depuy Synthes Sales INC. | $59.33 | 2019 | |
| Lifenet Health | $46.83 | 2024 | Theragenesis Wound Matrix |
| Sientra, INC. | $35.63 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $23.77 | 2025 | Wegovy |
| Acera Surgical, INC. | $23.10 | 2024 | Restrata Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $22.52 | 2025 | |
| Tei Biosciences INC | $18.83 | 2019 | |
| Polynovo North America LLC | $17.94 | 2023 | |
| Smith+Nephew, INC. | $14.63 | 2024 | Stravix |
| Checkpoint Surgical, INC | $13.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Azouz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.